Jeffrey L Larson Selected Research

oplunofusp

8/2011	A safety evaluation of DAS181, a sialidase fusion protein, in rodents.
8/2010	Antiviral strategies for pandemic and seasonal influenza.
4/2010	Sialidase-based anti-influenza virus therapy protects against secondary pneumococcal infection.
11/2009	Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein.
11/2009	Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey L Larson Research Topics

Disease

3	Human Influenza (Influenza) 08/2010 - 11/2009
2	Infections 08/2011 - 11/2009
2	Influenza in Birds (Avian Flu) 11/2009 - 11/2009
1	Neoplasm Metastasis (Metastasis) 11/2019
1	Osteosarcoma (Osteogenic Sarcoma) 11/2019
1	Body Weight (Weight, Body) 08/2011
1	Hemolysis 08/2011
1	Paramyxoviridae Infections (Parainfluenza) 08/2011
1	Anemia 08/2011
1	Bacterial Infections (Bacterial Infection) 04/2010
1	Pneumococcal Infections 04/2010
1	Pneumonia (Pneumonitis) 04/2010
1	Opportunistic Infections (Opportunistic Infection) 04/2010

Drug/Important Bio-Agent (IBA)

5	oplunofuspIBA 08/2011 - 11/2009
4	Neuraminidase (Sialidase)IBA 08/2010 - 11/2009
3	Proteins (Proteins, Gene)FDA Link 08/2010 - 11/2009
2	Pharmaceutical PreparationsIBA 08/2011 - 08/2010
2	Antiviral Agents (Antivirals)IBA 08/2010 - 11/2009
2	Oseltamivir (Tamiflu)FDA Link 11/2009 - 11/2009
1	CateninsIBA 11/2019
1	sialic acid receptorIBA 08/2011
1	VaccinesIBA 11/2009

Therapy/Procedure

3	Therapeutics 04/2010 - 11/2009
1	Drug Therapy (Chemotherapy) 11/2019